Stayble Therapeutics AB (publ) (FRA:4K4)
0.0162
-0.0010 (-5.81%)
Last updated: Jan 27, 2026, 3:25 PM CET
Stayble Therapeutics AB Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
2
Market Cap
1.28M EUR
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Manz AG | 205.12M |
| a.i.s. AG | 12.43M |
| Coreo AG | 12.24M |
| Medigene AG | 7.45M |
| Instant Group AG | 1.54M |
| Valora Effekten Handel AG | 782.05K |
| Arzneiwerk AG VIDA | 124.96K |
| CAMERIT AG | 100.00K |